Oscar Lao

Dr. Oscar Lao

Centre Nacional d'Anàlisi Genòmica, Centre de Regulació Genòmica (CNAG-CRG), Parc Científic de Barcelona - Torre R, Baldiri Reixac 4, 08028 Barcelona, Spain

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2016 in Nature
Verified
Journal Article
Closed access
PDF file
AMAnna-Sapfo Malaspinas
Anna-Sapfo Malaspinas
MWMichael C. Westaway
Michael C. Westaway
CMCraig Muller
Craig Muller
VSVitor C. Sousa
Vitor C. Sousa
Oscar LaoOscar Lao
Oscar Lao
EWEske Willerslev
Eske Willerslev

1 August 2008 in Current Biology
Verified
Journal Article
Closed access
Oscar LaoOscar Lao
Oscar Lao
TLTimothy T. Lu
Timothy T. Lu
MNMichael Nothnagel
Michael Nothnagel
OJOlaf Junge
Olaf Junge
SFSandra Freitag-Wolf
Sandra Freitag-Wolf
MKManfred Kayser
Manfred Kayser

1 September 2010 in The American Journal of Human Genetics
Verified
Journal Article
Open access
KBKaye N. Ballantyne
Kaye N. Ballantyne
MGMiriam Goedbloed
Miriam Goedbloed
RFRixun Fang
Rixun Fang
OSOnno Schaap
Onno Schaap
Oscar LaoOscar Lao
Oscar Lao
Manfred KayserManfred Kayser
Manfred Kayser
Nonrecombining Y-chromosomal microsatellites (Y-STRs) are widely used to infer population histories, discover genealogical relationships, and identify males for criminal justice purposes. Although a key requirement for their application is reliable mutability knowledge, empirical data are only available for a small number of Y-STRs thus far. To rectify this, we analyzed a large number of 186 Y-STR markers in nearly 2000 DNA-confirmed father-son pairs, covering an overall number of 352,999 meiotic transfers. Following confirmation by DNA sequence analysis, the retrieved mutation data were modeled via a Bayesian approach, resulting in mutation rates from 3.78 × 10(-4) (95% credible interval [CI], 1.38 × 10(-5) - 2.02 × 10(-3)) to 7.44 × 10(-2) (95% CI, 6.51 × 10(-2) - 9.09 × 10(-2)) per marker per generation. With the 924 mutations at 120 Y-STR markers, a nonsignificant excess of repeat losses versus gains (1.16:1), as well as a strong and significant excess of single-repeat versus multirepeat changes (25.23:1), was observed. Although the total repeat number influenced Y-STR locus mutability most strongly, repeat complexity, the length in base pairs of the repeated motif, and the father's age also contributed to Y-STR mutability. To exemplify how to practically utilize this knowledge, we analyzed the 13 most mutable Y-STRs in an independent sample set and empirically proved their suitability for distinguishing close and distantly related males. This finding is expected to revolutionize Y-chromosomal applications in forensic biology, from previous male lineage differentiation toward future male individual identification.

13 September 2012 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
FLFan Liu
Fan Liu
FLFedde van der Lijn
Fedde van der Lijn
CSClaudia Schurmann
Claudia Schurmann
GZGu Zhu
Gu Zhu
MCM Mallar Chakravarty
M Mallar Chakravarty
Manfred KayserManfred Kayser
Manfred Kayser
Inter-individual variation in facial shape is one of the most noticeable phenotypes in humans, and it is clearly under genetic regulation; however, almost nothing is known about the genetic basis of normal human facial morphology. We therefore conducted a genome-wide association study for facial shape phenotypes in multiple discovery and replication cohorts, considering almost ten thousand individuals of European descent from several countries. Phenotyping of facial shape features was based on landmark data obtained from three-dimensional head magnetic resonance images (MRIs) and two-dimensional portrait images. We identified five independent genetic loci associated with different facial phenotypes, suggesting the involvement of five candidate genes—PRDM16, PAX3, TP63, C5orf50, and COL17A1—in the determination of the human face. Three of them have been implicated previously in vertebrate craniofacial development and disease, and the remaining two genes potentially represent novel players in the molecular networks governing facial development. Our finding at PAX3 influencing the position of the nasion replicates a recent GWAS of facial features. In addition to the reported GWA findings, we established links between common DNA variants previously associated with NSCL/P at 2p21, 8q24, 13q31, and 17q22 and normal facial-shape variations based on a candidate gene approach. Overall our study implies that DNA variants in genes essential for craniofacial development contribute with relatively small effect size to the spectrum of normal variation in human facial morphology. This observation has important consequences for future studies aiming to identify more genes involved in the human facial morphology, as well as for potential applications of DNA prediction of facial shape such as in future forensic applications. Monozygotic twins look more alike than dizygotic twins or other siblings, and siblings in turn look more alike than unrelated individuals, indicating that human facial morphology has a strong genetic component. We quantitatively assessed human facial shape phenotypes based on statistical shape analyses of facial landmarks obtained from three-dimensional magnetic resonance images of the head. These phenotypes turned out to be highly promising for studying the genetic basis of human facial variation in that they showed high heritability in our twin data. A subsequent genome-wide association study (GWAS) identified five candidate genes affecting facial shape in Europeans: PRDM16, PAX3, TP63, C5orf50, and COL17A1. In addition, our data suggest that genetic variants associated with NSCL/P also influence normal facial shape variation. Overall, this study provides novel and confirmatory links between common DNA variants and normal variation in human facial morphology. Our results also suggest that the high heritability of facial phenotypes seems to be explained by a large number of DNA variants with relatively small individual effect size, a phenomenon well known for other complex human traits, such as adult body height.

1 June 2011 in Forensic Science International: Genetics
Verified
Journal Article
Closed access
SWSusan Walsh
Susan Walsh
FLFan Liu
Fan Liu
KBKaye N. Ballantyne
Kaye N. Ballantyne
MOMannis van Oven
Mannis van Oven
Oscar LaoOscar Lao
Oscar Lao
MKManfred Kayser
Manfred Kayser

1 February 2007 in Pharmacogenetics and Genomics
Verified
Journal Article
Closed access
JSJohanna Sistonen
Johanna Sistonen
ASAntti Sajantila
Antti Sajantila
Oscar LaoOscar Lao
Oscar Lao
JCJukka Corander
Jukka Corander
GBGuido Barbujani
Guido Barbujani
SFSilvia Fuselli
Silvia Fuselli
Background and objective CYP2D6, a member of the cytochrome P450 superfamily, is responsible for the metabolism of about 25% of the commonly prescribed drugs. Its activity ranges from complete deficiency to excessive activity, potentially causing toxicity of medication or therapeutic failure with recommended drug dosages. This study aimed to describe the CYP2D6 diversity at the global level. Methods A total of 1060 individuals belonging to 52 worldwide-distributed populations were genotyped at 12 highly informative variable sites, as well as for gene deletion and duplications. Phenotypes were predicted on the basis of haplotype combinations. Results and conclusions Our study shows that (i) CYP2D6 diversity is far greater within than between populations and groups thereof, (ii) null or low-activity variants occur at high frequencies in various areas of the world, (iii) linkage disequilibrium is lowest in Africa and highest in the Americas. Patterns of variation, within and among populations, are similar to those observed for other autosomal markers (e.g. microsatellites and protein polymorphisms), suggesting that the diversity observed at the CYP2D6 locus reflects the same factors affecting variation at random genome markers.